- Home
- MNOV vs FNGR Comparison
MNOV vs FNGR Comparison
Compare MNOV & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNOV | FNGR |
|---|---|---|
| Founded | 2000 | 2016 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7M | 74.8M |
| IPO Year | 2004 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MNOV | FNGR |
|---|---|---|
| Price | $1.38 | $1.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | 63.8K | ★ 158.0K |
| Earning Date | 05-12-2026 | 01-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,360,807.00 | ★ $35,607,614.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 194.15 | N/A |
| 52 Week Low | $1.13 | $1.05 |
| 52 Week High | $1.96 | $5.20 |
Technical Indicators
Market Signals| Indicator | MNOV | FNGR |
|---|---|---|
| Relative Strength Index (RSI) | 44.39 | 37.78 |
| Support Level | $1.22 | N/A |
| Resistance Level | $1.40 | $1.55 |
| Average True Range (ATR) | 0.06 | 0.11 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 17.64 | 1.80 |
Price Performance
Historical ComparisonAbout MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.